Previous Close | 246.53 |
Open | 246.73 |
Bid | 247.39 x 800 |
Ask | 247.51 x 900 |
Day's Range | 245.33 - 248.29 |
52 Week Range | 229.86 - 287.32 |
Volume | |
Avg. Volume | 1,472,524 |
Market Cap | 71.555B |
Beta (5Y Monthly) | 0.44 |
PE Ratio (TTM) | 56.81 |
EPS (TTM) | 4.36 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | 3.80 (1.54%) |
Ex-Dividend Date | Mar 07, 2024 |
1y Target Est | 278.54 |
Subscribe to Yahoo Finance Plus to view Fair Value for BDX
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey conducted by The Harris Poll that reveals that many patients receive too many needlesticks in hospital procedures and amplifies misconceptions and lack of awareness from Americans on the risks of common medical procedures.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2024 list of America's Most Innovative Companies.